Ketohexokinase-Dependent Fructose Metabolism as a Potential Upstream Amplifier of Mast-Cell Activation – A Hypothesis Linking Endogenous Fructose Production, Tissue Danger Signaling, and Impaired Recovery

Why do mast cells remain unusually responsive between episodes in some people with idiopathic mast-cell activation syndrome (MCAS)? We propose that fructose metabolism in surrounding tissue may help sustain this state. Ketohexokinase (KHK) begins fructose metabolism by spending ATP, a molecule that supplies energy for cellular work. If this initial processing outruns the cell’s capacity to handle the products and replenish ATP, it can disturb energy balance and promote oxidative stress. Fructose may come from the diet or be made within the body through the polyol pathway. We hypothesize that KHK-dependent tissue stress increases extracellular signals that heighten mast-cell responses. Mast-cell mediators could then reinforce tissue stress and delay recovery. This mechanism does not require mast cells themselves to lack ATP. Experimental studies support individual steps, but no study reviewed here establishes the complete connection in MCAS. We prioritize signals from neighboring tissue; direct fructose metabolism within mast cells requires separate validation. Proposed experiments would track fructose metabolism, transfer fluid from source tissue to human mast cells, and interrupt KHK separately in each cell population. In models showing both KHK activity and heightened mast-cell responsiveness, we predict that source-tissue KHK interruption will reduce this amplification and shorten recovery without impairing mast-cell function. Failure despite verified KHK inhibition over a predefined recovery interval would weaken the tested mechanism. Luteolin offers an additional probe because it independently inhibits mast-cell activity and shows experimental KHK inhibition; a response cannot identify which action matters. Clinical relevance requires validation in rigorously characterized MCAS populations.

Authors

Publication Details

Journal
Qeios
Published
2026-11-12
DOI
https://doi.org/10.32388/xc0xnn
Primary Topic
Mast cells and histamine
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Ketohexokinase-Dependent Fructose Metabolism as a Potential Upstream Amplifier of Mast-Cell Activation – A Hypothesis Linking Endogenous Fructose Production, Tissue Danger Signaling, and Impaired Recovery

Christopher Ryan Mearns
Qeios
Mast cells and histamine
preprint

Ketohexokinase-Dependent Fructose Metabolism as a Potential Upstream Amplifier of Mast-Cell Activation – A Hypothesis Linking Endogenous Fructose Production, Tissue Danger Signaling, and Impaired Recovery

Christopher Ryan Mearns
preprint en

Abstract

Why do mast cells remain unusually responsive between episodes in some people with idiopathic mast-cell activation syndrome (MCAS)? We propose that fructose metabolism in surrounding tissue may help sustain this state. Ketohexokinase (KHK) begins fructose metabolism by spending ATP, a molecule that supplies energy for cellular work. If this initial processing outruns the cell’s capacity to handle the products and replenish ATP, it can disturb energy balance and promote oxidative stress. Fructose may come from the diet or be made within the body through the polyol pathway. We hypothesize that KHK-dependent tissue stress increases extracellular signals that heighten mast-cell responses. Mast-cell mediators could then reinforce tissue stress and delay recovery. This mechanism does not require mast cells themselves to lack ATP. Experimental studies support individual steps, but no study reviewed here establishes the complete connection in MCAS. We prioritize signals from neighboring tissue; direct fructose metabolism within mast cells requires separate validation. Proposed experiments would track fructose metabolism, transfer fluid from source tissue to human mast cells, and interrupt KHK separately in each cell population. In models showing both KHK activity and heightened mast-cell responsiveness, we predict that source-tissue KHK interruption will reduce this amplification and shorten recovery without impairing mast-cell function. Failure despite verified KHK inhibition over a predefined recovery interval would weaken the tested mechanism. Luteolin offers an additional probe because it independently inhibits mast-cell activity and shows experimental KHK inhibition; a response cannot identify which action matters. Clinical relevance requires validation in rigorously characterized MCAS populations.

Qeios
Good health and well-being
Mast cells and histamine
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon